Cargando…
Pulmonary biomarkers in COPD exacerbations: a systematic review
Exacerbations of COPD (ECOPD) represent a major burden for patients and health care systems. Innovative sampling techniques have led to the identification of several pulmonary biomarkers. Although some molecules are promising, their usefulness in clinical practice is not yet established. Medline and...
Autores principales: | Koutsokera, Angela, Kostikas, Konstantinos, Nicod, Laurent P, Fitting, Jean-William |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014989/ https://www.ncbi.nlm.nih.gov/pubmed/24143945 http://dx.doi.org/10.1186/1465-9921-14-111 |
Ejemplares similares
-
Eosinopenia as a Prognostic Biomarker for Noninvasive Ventilation Use in COPD Exacerbations
por: Bartziokas, Konstantinos, et al.
Publicado: (2023) -
A Systematic Review of Diagnostic Biomarkers of COPD Exacerbation
por: Chen, Yu-Wei Roy, et al.
Publicado: (2016) -
Inhaled corticosteroid use by exacerbations and eosinophils: a real-world COPD population
por: Vestbo, Jørgen, et al.
Publicado: (2019) -
The Role of Digital Tools in the Timely Diagnosis and Prevention of Acute Exacerbations of COPD: A Comprehensive Review of the Literature
por: Konstantinidis, Athanasios, et al.
Publicado: (2022) -
Evaluation of exacerbations and blood eosinophils in UK and US COPD populations
por: Vogelmeier, Claus F., et al.
Publicado: (2019)